We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI Model Accurately Predicts Malignancy on Breast Ultrasound

By MedImaging International staff writers
Posted on 22 Dec 2023
Print article
Image: An AI model accurately predicts malignancy on breast ultrasound based on BI-RADS assessment (Photo courtesy of 123RF)
Image: An AI model accurately predicts malignancy on breast ultrasound based on BI-RADS assessment (Photo courtesy of 123RF)

Artificial intelligence (AI) systems are increasingly being integrated into breast ultrasonography to potentially reduce radiologists' workload and enhance diagnostic precision. Now, a new study that evaluated an AI system's performance in BI-RADS category assessment for breast masses detected on ultrasound has found that the technology can effectively predict malignancy.

The study, conducted at Acibadem Altunizade Hospital (Istanbul, Turkey), involved the analysis of 715 masses across 530 patients. It engaged three breast imaging centers from the same institution and nine breast radiologists. Ultrasound examinations were carried out by one radiologist capturing two orthogonal views of each lesion. These images were then retrospectively examined by a second radiologist who was not privy to the patient’s clinical information. A commercially available AI system also evaluated the images. The researchers measured the level of concordance between the AI system and the radiologists, along with their diagnostic effectiveness, according to the dichotomous BI-RADS category assessment.

The study noted a moderate level of concordance between the AI model and the radiologists in differentiating benign and probably benign lesions from those deemed suspicious. The AI model ascertained that none of the lesions categorized as BI-RADS 2 were malignant, although two classified as BI-RADS 3 were confirmed malignant. The researchers highlighted that considering BI-RADS 2 lesions identified by AI as non-threatening could allow radiologists to avoid numerous unnecessary benign lesion biopsies and a significant number of follow-ups. Additionally, the AI algorithm potentially downgraded a considerable percentage of BI-RADS 3, 4, and 5 lesions to BI-RADS 2 or 3 and upgraded numerous benign or possibly benign lesions as suspicious, albeit with a low malignancy risk. The researchers concluded that AI holds promise in accurately predicting malignancy, and its integration into clinical workflows could reduce unnecessary biopsies and follow-ups, thereby enhancing sustainability in healthcare practices.

Related Links:
Acibadem Altunizade Hospital 

Portable X-ray Unit
AJEX140H
New
Mobile X-Ray Machine
MARS 15 / 30
New
Biopsy Software
Affirm® Contrast
Portable Color Doppler Ultrasound System
S5000

Print article

Channels

MRI

view channel
Image: An AI tool has shown tremendous promise for predicting relapse of pediatric brain cancer (Photo courtesy of 123RF)

AI Tool Predicts Relapse of Pediatric Brain Cancer from Brain MRI Scans

Many pediatric gliomas are treatable with surgery alone, but relapses can be catastrophic. Predicting which patients are at risk for recurrence remains challenging, leading to frequent follow-ups with... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.